Most people will have heard the term "man flu", which refers to men's perceived tendency to exaggerate the severity of a cold or a similar minor ailment.
Aug 17, 2023
0
1
People suffering from blood cancer often have a weak immune system, putting them at higher risk of falling seriously ill with COVID-19. Some cancer therapies, moreover, result in these patients forming few or no antibodies ...
Dec 22, 2022
3
21
B cells maintain stockpiles of calcium ions (Ca2+), which are released during the course of the immune response. When the presence of a foreign antigen stimulates the B cell receptor (BCR) complex, these internal reserves ...
Jul 22, 2011
0
0
(Medical Xpress)—Researchers at Kanazawa University Graduate School of Medical Science in Japan have determined how APOBEC proteins mediate hypermutations that inhibit viral replication. They also identify the host factor ...
Jun 25, 2013
0
0
COVID-19 vaccines may provide protection for at least a year, and possibly even a lifetime, to people who were previously exposed to the virus, two new studies suggest.
May 28, 2021
0
3
Cancer myths irritate me. Not only because they fly in the face of scientific research, but also because they prey upon people who are just trying to do their best to live a healthy life.
Nov 7, 2019
0
2
Monash University researchers have found an important safety mechanism in the immune system that may malfunction in people with autoimmune diseases, such as Multiple Sclerosis, potentially paving the way for innovative treatments.
Sep 5, 2013
0
0
A University of Colorado Boulder-led team has discovered two prime targets of the Hepatitis B virus in liver cells, findings that could lead to treatment of liver disease in some of the 400 million people worldwide currently ...
Oct 22, 2012
0
0
In a study published in the journal Arthritis & Rheumatology, Prof. Zhang Xiaoming's group at the Shanghai Institute Immunity and Infection of the Chinese Academy of Sciences, Prof. Gu Zhifeng at Affiliated Hospital of Nantong ...
Nov 27, 2023
0
1
Researchers at Stanford University have developed "decoy receptor" molecules that inhibit the growth of both multiple myeloma (MM) and diffuse large B cell lymphoma (DLBCL) in mice. The molecules, described in a study to ...
Jul 26, 2022
0
6
